NASDAQ:PEAK - Healthpeak Properties Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $28.82
  • Forecasted Upside: 0.17 %
  • Number of Analysts: 13
  • Breakdown:
  • 0 Sell Ratings
  • 7 Hold Ratings
  • 6 Buy Ratings
  • 0 Strong Buy Ratings
$28.77
▲ +0.3 (1.05%)
1 month | 3 months | 12 months
Get New Healthpeak Properties Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PEAK and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PEAK

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$28.82
▲ +0.17% Upside Potential
This price target is based on 13 analysts offering 12 month price targets for Healthpeak Properties in the last 3 months. The average price target is $28.82, with a high forecast of $31.00 and a low forecast of $26.00. The average price target represents a 0.17% upside from the last price of $28.77.
Hold
The current consensus among 13 contributing investment analysts is to hold stock in Healthpeak Properties.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/3/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/1/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/30/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/28/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 6 hold ratings
  • 0 sell ratings
4/27/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 7 hold ratings
  • 0 sell ratings
7/26/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 7 hold ratings
  • 0 sell ratings
9/24/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 7 hold ratings
  • 0 sell ratings
10/24/2020

Latest Recommendations

  • 0 strong buy ratings
  • 6 buy ratings
  • 7 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/16/2020MizuhoDowngradeBuy ➝ Neutral$30.00 ➝ $29.00Medium
i
9/4/2020BarclaysBoost Price TargetOverweight$28.00 ➝ $30.00Low
i
9/1/2020Stifel NicolausInitiated CoverageBuy$31.00High
i
8/21/2020Morgan StanleyBoost Price TargetEqual Weight$28.00 ➝ $29.00Low
i
7/2/2020CitigroupBoost Price TargetNeutral$24.00 ➝ $28.00Low
i
7/2/2020Berenberg BankInitiated CoverageHoldLow
i
5/22/2020BMO Capital MarketsReiterated RatingBuy$30.00Low
i
5/14/2020Royal Bank of CanadaLower Price Target$32.00 ➝ $27.00High
i
4/29/2020Raymond JamesDowngradeOutperform ➝ Market PerformHigh
i
4/21/2020MizuhoLower Price TargetBuy$41.00 ➝ $30.00Low
i
Rating by Omotayo Okusanya at Mizuho
4/21/2020KeyCorpLower Price TargetOverweight$37.00 ➝ $30.00High
i
4/14/2020Royal Bank of CanadaReiterated RatingBuy$32.00Low
i
4/8/2020BarclaysReiterated RatingBuy$28.00High
i
4/7/2020CitigroupLower Price TargetNeutral$38.00 ➝ $24.00High
i
4/3/2020JPMorgan Chase & Co.Lower Price TargetOverweight$38.00 ➝ $29.00Medium
i
3/27/2020Wells Fargo & CompanyLower Price TargetEqual Weight$35.00 ➝ $26.00Medium
i
3/25/2020Raymond JamesLower Price TargetOutperform$37.00 ➝ $28.00High
i
3/23/2020Bank of AmericaDowngradeBuy ➝ NeutralHigh
i
3/17/2020Morgan StanleyLower Price TargetEqual Weight$35.00 ➝ $28.00High
i
3/9/2020Royal Bank of CanadaReiterated RatingBuy$40.00Medium
i
2/13/2020BMO Capital MarketsReiterated RatingBuy$38.00High
i
2/12/2020MizuhoReiterated RatingBuy$38.00High
i
Rating by Omotayo Okusanya at Mizuho
12/19/2019MizuhoInitiated CoverageBuy$39.00High
i
2/5/2016MacquarieDowngradeNeutral ➝ UnderperformN/A
i
12/16/2015Janney Montgomery ScottReiterated RatingBuy$9.00 ➝ $8.00N/A
i
11/4/2015Janney Montgomery ScottReiterated RatingBuy$9.00N/A
i
(Data available from 10/24/2015 forward)
Healthpeak Properties logo
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns and develops high-quality real estate in the three private-pay healthcare asset classes of Life Science, Senior Housing and Medical Office, designed to provide stability through the inevitable industry cycles. At Healthpeak, we pair our deep understanding of the healthcare real estate market with a strong vision for long-term growth. For more information regarding Healthpeak, visit www.healthpeak.com. Healthpeak's common stock is expected to begin trading under its new name and ticker symbol "PEAK" on the New York Stock Exchange on November 5, 2019.
Read More

Today's Range

Now: $28.77
$28.61
$28.99

50 Day Range

MA: $27.70
$25.58
$29.04

52 Week Range

Now: $28.77
$18.63
$37.93

Volume

3,579,287 shs

Average Volume

4,210,031 shs

Market Capitalization

$15.49 billion

P/E Ratio

N/A

Dividend Yield

5.20%

Beta

N/A